| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |